Truffle Hound Capital LLC Purchases New Shares in FONAR Co. (NASDAQ:FONR)

Truffle Hound Capital LLC purchased a new stake in shares of FONAR Co. (NASDAQ:FONR) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 90,000 shares of the medical equipment provider’s stock, valued at approximately $1,363,000. Truffle Hound Capital LLC owned approximately 1.42% of FONAR as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Money Concepts Capital Corp boosted its position in shares of FONAR by 5.9% during the fourth quarter. Money Concepts Capital Corp now owns 401,577 shares of the medical equipment provider’s stock valued at $6,080,000 after purchasing an additional 22,245 shares in the last quarter. Peapod Lane Capital LLC bought a new stake in shares of FONAR during the fourth quarter valued at approximately $2,159,000. Linden Thomas Advisory Services LLC boosted its position in shares of FONAR by 15.1% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 29,236 shares of the medical equipment provider’s stock valued at $443,000 after purchasing an additional 3,837 shares in the last quarter. Corsair Capital Management L.P. boosted its position in shares of FONAR by 8.8% during the third quarter. Corsair Capital Management L.P. now owns 27,972 shares of the medical equipment provider’s stock valued at $453,000 after purchasing an additional 2,266 shares in the last quarter. Finally, Empowered Funds LLC boosted its position in shares of FONAR by 5.1% during the fourth quarter. Empowered Funds LLC now owns 19,635 shares of the medical equipment provider’s stock valued at $297,000 after purchasing an additional 945 shares in the last quarter. 50.64% of the stock is currently owned by institutional investors.

FONAR Stock Up 0.2 %

NASDAQ FONR opened at $13.84 on Friday. FONAR Co. has a twelve month low of $13.27 and a twelve month high of $22.39. The firm has a market capitalization of $85.85 million, a PE ratio of 12.03 and a beta of 1.27. The stock’s 50 day moving average is $15.05 and its 200 day moving average is $15.55.

FONAR (NASDAQ:FONR) last released its earnings results on Wednesday, February 19th. The medical equipment provider reported $0.29 EPS for the quarter. FONAR had a return on equity of 4.94% and a net margin of 7.68%. The business had revenue of $24.95 million for the quarter.

FONAR Company Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.